ARS Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Hold
2,750
0.06% 95
2026
Q1
$1.35M Sell
2,750
-12
-0.4% -$6.51K 0.07% 87
2025
Q4
$1.6M Buy
2,762
+57
+2% +$32.2K 0.09% 81
2025
Q3
$1.31M Hold
2,705
0.09% 89
2025
Q2
$1.1M Sell
2,705
-72
-3% -$30.1K 0.08% 94
2025
Q1
$1.44M Hold
2,777
0.13% 74
2024
Q4
$1.44M Hold
2,777
0.13% 74
2024
Q3
$1.72M Sell
2,777
-26
-0.9% -$15.4K 0.15% 68
2024
Q2
$1.55M Sell
2,803
-479
-15% -$274K 0.15% 64
2024
Q1
$1.91M Hold
3,282
0.19% 60
2023
Q4
$1.74M Hold
3,282
0.19% 62
2023
Q3
$1.66M Hold
3,282
0.21% 61
2023
Q2
$1.71M Buy
3,282
+75
+2% +$40.5K 0.2% 60
2023
Q1
$1.85M Buy
3,207
+125
+4% +$70.5K 0.22% 60
2022
Q4
$1.7M Hold
3,082
0.23% 59
2022
Q3
$1.56M Sell
3,082
-155
-5% -$86.7K 0.21% 63
2022
Q2
$1.76M Buy
3,237
+40
+1% +$22K 0.24% 59
2022
Q1
$1.89M Sell
3,197
-115
-3% -$66.1K 0.18% 69
2021
Q4
$2.21M Hold
3,312
0.2% 65
2021
Q3
$1.89M Hold
3,312
0.19% 67
2021
Q2
$1.67M Buy
3,312
+87
+3% +$41K 0.17% 68
2021
Q1
$1.47M Buy
3,225
+3
+0.1% +$1.43K 0.17% 67
2020
Q4
$1.5M Hold
3,222
0.18% 64
2020
Q3
$1.42M Hold
3,222
0.22% 60
2020
Q2
$1.17M Hold
3,222
0.22% 44
2020
Q1
$914K Hold
3,222
0.22% 53
2019
Q4
$1.05M Hold
3,222
0.18% 69
2019
Q3
$938K Sell
3,222
-50
-2% -$14.3K 0.17% 67
2019
Q2
$961K Sell
3,272
-18
-0.5% -$4.96K 0.16% 77
2019
Q1
$901K Hold
3,290
0.16% 77
2018
Q4
$736K Sell
3,290
-21
-0.6% -$4.93K 0.16% 78
2018
Q3
$808K Hold
3,311
0.13% 93
2018
Q2
$686K Hold
3,311
0.11% 93
2018
Q1
$684K Hold
3,311
0.08% 119
2017
Q4
$629K Sell
3,311
-27
-0.8% -$5.17K 0.08% 131
2017
Q3
$632K Buy
3,338
+18
+0.5% +$3.26K 0.08% 124
2017
Q2
$579K Hold
3,320
0.08% 126
2017
Q1
$510K Buy
3,320
+55
+2% +$8.41K 0.07% 124
2016
Q4
$461K Sell
3,265
-41,928
-93% -$6.18M 0.07% 131
2016
Q3
$7.19M Sell
45,193
-268
-0.6% -$41.3K 1.58% 24
2016
Q2
$6.72M Buy
45,461
+26,155
+135% +$3.86M 1.5% 29
2016
Q1
$2.73M Sell
19,306
-1,202
-6% -$161K 0.64% 50
2015
Q4
$2.91M Sell
20,508
-142
-0.7% -$18.9K 0.68% 50
2015
Q3
$2.52M Buy
20,650
+855
+4% +$111K 0.58% 54
2015
Q2
$2.57M Buy
19,795
+1,190
+6% +$155K 0.47% 59
2015
Q1
$2.5M Buy
+18,605
New +$2.4M 0.46% 57

Other funds holding TMO

ARS Investment Partners's TMO Position: Q2 2026 in Review

ARS Investment Partners held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,750 shares worth $1.38M. The position accounts for 0.06% of the portfolio, ranked #95.

ARS Investment Partners first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.19M in Q3 2016. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • ARS Investment Partners held 2,750 shares of Thermo Fisher Scientific worth $1.38M as of Q2 2026.
  • ARS Investment Partners left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.06% of ARS Investment Partners's portfolio in Q2 2026, its #95 holding.
  • ARS Investment Partners first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
  • ARS Investment Partners's Thermo Fisher Scientific position peaked at $7.19M in Q3 2016.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.